Insight Molecular Diagnostics (IMDX) Receivables - Other (2017)

Insight Molecular Diagnostics (IMDX) posted Receivables - Other of $55000.0 for Q3 2017, up 66.67% sequentially from $33000.0 in Q2 2017.

Insight Molecular Diagnostics (IMDX) Receivables - Other (2017) Analysis & Trends

Insight Molecular Diagnostics has reported Receivables - Other for 1 years, with the latest figure at $55000.0 in Q3 2017.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Thermo Fisher Scientific	234.15 Bn	230.09 Bn	8.34 Bn
2	Danaher	152.10 Bn	147.75 Bn	3.61 Bn
3	Natera	48.48 Bn	47.38 Bn	486.15 Mn
4	Agilent Technologies	44.35 Bn	42.55 Bn	990.00 Mn
5	Iqvia Holdings	43.68 Bn	41.60 Bn	1.44 Bn
6	Idexx Laboratories	43.02 Bn	42.83 Bn	779.09 Mn
7	Illumina	34.39 Bn	33.22 Bn	770.00 Mn
8	Mettler Toledo International	28.29 Bn	28.24 Bn	650.22 Mn
9	Labcorp Holdings	27.51 Bn	27.37 Bn	1.11 Bn
10	Insight Molecular Diagnostics	158.03 Mn	139.50 Mn	157,000.00

Download Data